Clinical Trial Update: Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma

View source ↗

Summary

ClinicalTrials.gov entry for a case-control study comparing the Glycotest HCC Panel to AFP for early detection of hepatocellular carcinoma; the study is active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• Glycotest HCC Panel

Snippet

Sponsor: Glycotest, Inc. | Conditions: Carcinoma, Hepatocellular, Cirrhosis, Liver | Status: ACTIVE_NOT_RECRUITING